-
Signature
-
/s/ Daniel Rodriguez as Attorney-in-Fact for Kevin Yeaman
-
Issuer symbol
-
DLB
-
Transactions as of
-
15 Jul 2025
-
Net transactions value
-
-$910,771
-
Form type
-
4
-
Filing time
-
17 Jul 2025, 20:16:40 UTC
Reporting Owners (1)
| Name |
Relationship |
Address |
Signature |
Signature date |
CIK |
| YEAMAN KEVIN J |
President and CEO, Director |
C/O DOLBY LABORATORIES, INC., 1275 MARKET STREET, SAN FRANCISCO |
/s/ Daniel Rodriguez as Attorney-in-Fact for Kevin Yeaman |
17 Jul 2025 |
0001200469 |
Transactions Table
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
| transaction |
DLB |
Class A Common Stock |
Options Exercise |
$1,137,500 |
+25,000 |
+22% |
$45.50 |
139,725 |
15 Jul 2025 |
By a trust |
F1 |
| transaction |
DLB |
Class A Common Stock |
Options Exercise |
$960,925 |
+14,875 |
+11% |
$64.60 |
154,600 |
15 Jul 2025 |
By a trust |
F1 |
| transaction |
DLB |
Class A Common Stock |
Sale |
$2,962,205 |
-39,595 |
-26% |
$74.81 |
115,005 |
15 Jul 2025 |
By a trust |
F1, F2 |
| transaction |
DLB |
Class A Common Stock |
Sale |
$21,085 |
-280 |
-0.24% |
$75.30 |
114,725 |
15 Jul 2025 |
By a trust |
F1, F3 |
| transaction |
DLB |
Class A Common Stock |
Options Exercise |
$160,919 |
+2,491 |
+2.2% |
$64.60 |
117,216 |
16 Jul 2025 |
By a trust |
F1 |
| transaction |
DLB |
Class A Common Stock |
Sale |
$186,825 |
-2,491 |
-2.1% |
$75.00 |
114,725 |
16 Jul 2025 |
By a trust |
F1 |
| holding |
DLB |
Class A Common Stock |
|
|
|
|
|
127,735 |
15 Jul 2025 |
Direct |
F4 |
| holding |
DLB |
Class A Common Stock |
|
|
|
|
|
3 |
15 Jul 2025 |
By a son |
|
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
| transaction |
DLB |
Employee Stock Option (Right to Buy) |
Options Exercise |
$0 |
-25,000 |
-18% |
$0.000000 |
110,615 |
15 Jul 2025 |
Class A Common Stock |
25,000 |
$45.50 |
By a trust |
F1, F5 |
| transaction |
DLB |
Employee Stock Option (Right to Buy) |
Options Exercise |
$0 |
-14,875 |
-28% |
$0.000000 |
37,942 |
15 Jul 2025 |
Class A Common Stock |
14,875 |
$64.60 |
By a trust |
F1, F6 |
| transaction |
DLB |
Employee Stock Option (Right to Buy) |
Options Exercise |
$0 |
-2,491 |
-6.6% |
$0.000000 |
35,451 |
16 Jul 2025 |
Class A Common Stock |
2,491 |
$64.60 |
By a trust |
F1, F6 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: